OT ULTRA2 METER
Report
- Report Number
- 2939301-2010-09785
- Event Type
- Injury
- Date Received
- November 10, 2010
- Date of Event
- October 23, 2010
- Report Date
- October 25, 2010
- Manufacturer
- LIFESCAN INC.
- Product Code
- NBW
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- FL, US
- Reporter Occupation
- OTHER
Narratives
THE 510(K) # IS K053529. THE LAY USER/PATIENT'S METER HAS BEEN RETURNED AND EVALUATED BY LIFESCAN PRODUCT ANALYSIS WITH THE FOLLOWING FINDINGS: THE METER INVOLVED IN THIS CASE HAS PASSED TESTING WITH NO FAULTS FOUND. IF ANY ADDITIONAL INFORMATION IS AVAILABLE, THE FDA WILL BE NOTIFIED IN A FOLLOW UP REPORT. AT THIS TIME, WE CONSIDER THIS MATTER CLOSED.
(B)(4). THE LAY USER/PATIENT'S METER HAS BEEN RETURNED AND EVALUATED BY LIFESCAN PRODUCT ANALYSIS WITH THE FOLLOWING FINDINGS:THE METER INVOLVED IN THIS CASE HAS PASSED TESTING WITH NO FAULTS FOUND. IF ANY ADDITIONAL INFORMATION IS AVAILABLE, THE FDA WILL BE NOTIFIED IN A SECOND FOLLOW UP REPORT. AT THIS TIME, WE CONSIDER THIS MATTER CLOSED.
ON (B)(6) 2010, THE LAY USER/PATIENT CONTACTED LIFESCAN (LFS) ALLEGING THAT HER ONETOUCH ULTRA2 METER WAS PROMPTING AN ERROR 2 MESSAGE. THE MEDICAL SURVEILLANCE SPECIALIST (MSS) WAS UNABLE TO REACH THE LAY USER/ PATIENT BY PHONE FOR FOLLOW-UP QUESTIONS. THE FOLLOWING COMPLAINT WAS CLASSIFIED BASED ON INFORMATION OBTAINED FROM THE CUSTOMER SERVICE REPRESENTATIVE (CSR). THE PATIENT ALLEGED THAT THE ISSUE BEGAN ON (B)(6) 2010 AT 6AM. THE PATIENT INDICATED SHE MANAGES HER DIABETES WITH INSULIN (NO ADJUSTMENTS); HOWEVER, THE PATIENT DENIED TAKING ANY ACTION IN RESPONSE TO THE ALLEGED METER ISSUE. ACCORDING TO THE CSR'S DOCUMENTATION, IMMEDIATELY AFTER THE ALLEGED ISSUE OCCURRED (TIME NOT SPECIFIED), THE PATIENT EXPERIENCED A SYMPTOM OF SHAKING. THE PATIENT DENIED SHE RECEIVED MEDICAL INTERVENTION OR TREATMENT AS A RESULT OF THE REPORTED ISSUE. IT IS NOT KNOWN HOW LONG THE PATIENT'S SYMPTOM LASTED, IT IS NOT SPECIFIED IF THE PATIENT ASSOCIATED THE SYMPTOM WITH HIGH OR LOW BLOOD GLUCOSE, AND IT IS ALSO NOT SPECIFIED IF THE PATIENT TESTED WITH ANOTHER DEVICE. DURING TROUBLESHOOTING, THE CSR CONFIRMED THE PATIENT WAS USING PROPER TESTING TECHNIQUE AND THE CORRECT TEST STRIPS; HOWEVER, THE CSR NOTED THE PATIENT DID NOT HAVE HER TEST STRIPS AVAILABLE AT THE TIME OF THE CALL. THE ALLEGED ISSUE REMAINS UNRESOLVED. REPLACEMENT PRODUCTS WERE SENT TO THE PATIENT. BASED ON THE INFORMATION PROVIDED, THIS COMPLAINT IS BEING REPORTED DUE TO THE FOLLOWING CONCLUSION: THE PATIENT CLAIMED THAT SHE DEVELOPED A SYMPTOM THAT CAN BE ASSOCIATED WITH A SERIOUS INJURY AFTER THE ALLEGED ISSUE BEGAN.
IT WAS REPORTED THAT PACKAGING WITH CHANNEL SEAL WAS FOUND TO HAVE INADEQUATE COMPONENT HOLDING, THIS WAS DISCOVERED DURING THE AFFILIATE'S LABELING PROCESS.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | OT ULTRA2 METER | GLUCOSE MONITORING SYS/KIT | NBW | LIFESCAN INC. | 3011992 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 80 YR | Life Threatening |